Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01470209
Title A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Emory University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Winship Cancer Institute of Emory University Atlanta Georgia 30322 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field